JoyCom Group, founded in 2006, is an internationally oriented pharmaceutical and biotechnology company built on patented innovation. We specialize in damaged tissue repair and women’s health solutions, integrating scientific expertise with global commercialization strategy.
Originating from our flagship active wound dressing NewEpi®, we have remained committed to addressing unmet clinical needs through sustained R&D and technological advancement. To date, JoyCom holds 22 international patents across Taiwan, the United States, Germany, Japan, and China; nine TFDA medical device approvals; and over 70 registered trademarks worldwide, forming a robust and globally competitive intellectual property portfolio.
Our products have received distinguished recognitions, including the Taiwan Excellence Award and the World Halal Excellence Brand Award, underscoring our achievements in research excellence, clinical application, and brand value.
Originating from our flagship active wound dressing NewEpi®, we have remained committed to addressing unmet clinical needs through sustained R&D and technological advancement. To date, JoyCom holds 22 international patents across Taiwan, the United States, Germany, Japan, and China; nine TFDA medical device approvals; and over 70 registered trademarks worldwide, forming a robust and globally competitive intellectual property portfolio.
Our products have received distinguished recognitions, including the Taiwan Excellence Award and the World Halal Excellence Brand Award, underscoring our achievements in research excellence, clinical application, and brand value.
Combining patented raw materials and technologies,
dedicated to medical innovation and research
Guided by the principle of “Patents at the Core, Technology as the Foundation,” JoyCom Group integrates proprietary patented ingredients with critical manufacturing processes, continuously investing in research and applications across diverse healthcare sectors:
- Advanced Wound Care & Damaged Tissue Repair Solutions
Built upon extensive clinical experience, we deliver medical solutions characterized by demonstrable reparative efficacy and consistent, reliable quality.
- Women’s Intimate Health & Microbiome Balance Care
Focusing on the evolving needs of women’s health, we develop innovative products that prioritize safety, gentleness, and long-term usability while supporting microbiome balance.
- Medical Devices & Formulations with Clinical Application Potential
From the earliest stages of development, regulatory strategy and market feasibility are incorporated into our R&D framework, ensuring sustainable commercialization and global expansion potential.
Rather than pursuing short-term market trends, JoyCom is committed to developing products that are patent-protected, regulatory-supported, and validated by long-term market performance — forming the cornerstone of the Group’s stable and sustainable growth.
The protective umbrella of active ingredients ：
Patented microencapsulated technology
To enhance product efficacy and stability, JoyCom Group has developed a patent-protected microencapsulation technology that effectively safeguards active ingredients, improving their stability and functional performance in clinical settings.
This proprietary technology not only serves as a key differentiator across our product portfolio, but also represents a core element of JoyCom’s long-term R&D capabilities and technological barrier to entry.
This proprietary technology not only serves as a key differentiator across our product portfolio, but also represents a core element of JoyCom’s long-term R&D capabilities and technological barrier to entry.
Comprehensive Healthcare Solutions,
Expanding with Steady Global Reach
Guided by a mission to deliver comprehensive healthcare solutions, JoyCom Group has achieved cumulative global sales of over 15 million units of its patented products. Our portfolio spans innovative pharmaceuticals, medical devices, personal care products, and animal health solutions.
Supported by strong capabilities in patented R&D, quality management, and international market experience, JoyCom continues to grow steadily and is committed to becoming a long-term, trusted partner in the global healthcare industry.
